Sunshine Biopharma (SBFM) Metrics: History & Chart

Sunshine Biopharma, Inc.(SBFM)

Drug Manufacturers - Specialty & Generic · Fort Lauderdale, FL

$0.36-0.06 (-14.09%)

Delayed quote: Oct 6, 2026, 2:49 PM EDT

About Sunshine Biopharma, Inc.

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.

Fort Lauderdale, FL

50 employees

www.sunshinebiopharma.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Steve N. Slilaty

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	0.00%
30D Total Return	0.00%
YTD Total Return	-66.67%
1Y Total Return	-75.00%
3Y Total Return	N/A
5Y Total Return	N/A
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	N/A
2025	-57.14%
2024	-99.48%
2023	-57.58%
2022	-78.10%
2021	+272.31%
2020

CAGR TTM	N/A
CAGR 3Y	N/A
CAGR 5Y	N/A
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

SBFM Valuation Metrics

SBFM Stock Price Metrics

SBFM Dividend Metrics

SBFM Growth Rate Metrics

SBFM Discounted Cash Flow Metrics

SBFM Returns By Period

SBFM Yearly Returns

SBFM Average Annual Returns By Period (CAGR)

SBFM Revenue Metrics

SBFM PE Ratio Metrics

SBFM PS Ratio Metrics

SBFM PB Ratio Metrics

SBFM Price to Free Cash Flow Ratio Metrics

SBFM Debt to Equity Ratio Metrics

SBFM PEG Ratio Metrics

SBFM FCF Yield

SBFM Earnings Yield

SBFM EBITDA Yield

SBFM OCF Yield

SBFM EV/EBIT Ratio Metrics

SBFM EV/EBITDA Ratio Metrics

SBFM EV/Assets Ratio Metrics

SBFM EV/Sales Ratio Metrics

SBFM Current Ratio Metrics

SBFM Quick Ratio Metrics

SBFM ROIC Metrics

SBFM Return on Assets Metrics

SBFM Return on Equity Metrics

SBFM Net Profit Margin Metrics

SBFM Gross Profit Margin Metrics

SBFM Tax Rate Metrics

PS Ratio	0.02
PS Ratio Avg TTM	0.09
PS Ratio Avg 3Y	0.08
Current VS TTM Avg	-76.82%
Current VS 3Y Avg	-73.99%
Current VS 5Y Avg	-99.93%

PB Ratio	0.02
PB Ratio Avg TTM	0.13
PB Ratio Avg 3Y	0.12
Current VS TTM Avg	-85.06%
Current VS 3Y Avg	-83.11%
Current VS 5Y Avg	-95.55%

PFCF Ratio	11083.05
PFCF Ratio Avg TTM	13238.57
PFCF Ratio Avg 3Y	13238.57
Current VS TTM Avg	-16.28%
Current VS 3Y Avg	-16.28%
Current VS 5Y Avg	-16.28%

Debt/Equity Ratio	0.02
Debt/Equity Ratio Avg TTM	0.03
Debt/Equity Ratio Avg 3Y	0.03
Current VS TTM Avg	-25.81%
Current VS 3Y Avg	-22.28%
Current VS 5Y Avg	-23.85%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	0.01%
FCF Yield Avg TTM	0.01%
FCF Yield Avg 3Y	0.01%
Current VS TTM Avg	-0.00%
Current VS 3Y Avg	-0.00%
Current VS 5Y Avg	-0.00%

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	22.00
Ev/Assets Ratio Avg TTM	605.10
Ev/Assets Ratio Avg 3Y	7262.77
Current VS TTM Avg	-96.36%
Current VS 3Y Avg	-99.70%
Current VS 5Y Avg	-99.47%

Ev/Sales Ratio	43.03
Ev/Sales Ratio Avg TTM	4140.29
Ev/Sales Ratio Avg 3Y	110810.76
Current VS TTM Avg	-98.96%
Current VS 3Y Avg	-99.96%
Current VS 5Y Avg	-99.84%

Current Ratio	5.46
Current Ratio Avg TTM	4.61
Current Ratio Avg 3Y	4.73
Current VS TTM Avg	+18.42%
Current VS 3Y Avg	+15.37%
Current VS 5Y Avg	+20.23%

Quick Ratio	3.30
Quick Ratio Avg TTM	2.42
Quick Ratio Avg 3Y	2.99
Current VS TTM Avg	+36.32%
Current VS 3Y Avg	+10.20%
Current VS 5Y Avg	+5.12%

ROIC	(18.56%)
ROIC Avg 3Y	(20.33%)
ROIC Avg 5Y	(52.23%)
Current VS 3Y Avg	+8.70%
Current VS 5Y Avg	+64.47%
Current VS 10Y Avg	+74.19%

ROA	(17.34%)
ROA Avg TTM	(4.91%)
ROA Avg 3Y	(3.75%)
Current VS TTM Avg	-252.91%
Current VS 3Y Avg	-361.93%
Current VS 5Y Avg	-288.66%

ROE	(21.18%)
ROE Avg TTM	(24.90%)
ROE Avg 3Y	(21.71%)
Current VS TTM Avg	+14.94%
Current VS 3Y Avg	+2.42%
Current VS 5Y Avg	+5.46%

Net Profit Margin	(16.50%)
Net Profit Margin Avg TTM	(17.08%)
Net Profit Margin Avg 3Y	(15.53%)
Current VS TTM Avg	+3.42%
Current VS 3Y Avg	-6.22%
Current VS 5Y Avg	+77.84%

Gross Profit Margin	29.80%
Gross Pft Margin Avg TTM	31.08%
Gross Pft Margin Avg 3Y	32.12%
Current VS TTM Avg	-4.11%
Current VS 3Y Avg	-7.22%
Current VS 5Y Avg	-7.23%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A